@OncoAlert @brunolarvol @adamfeuerstein An alleged third-party leak of the top plenary presentation of the #interpath-001 at #ESMO2026 . Source still unknown. #Intismeran autogene + pembro reportedly reduced recurrence or death (EFS) risk by 42% (HR 0.58) for resected IIB-IV #melanoma Possible #PracticeChanging pending safety and full text publication